Read More Pharma Industry News Lupin secures Health Canada approval for Enbrel biosimilar – Rymti Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor… bySrinathSeptember 13, 2022